Caricamento...
Reversing multidrug resistance by tyrosine kinase inhibitors
Recently, a large number of tyrosine kinase inhibitors (TKIs) have been developed as anticancer agents. These TKIs can specifically and selectively inhibit tumor cell growth and metastasis by targeting various tyrosine kinases and thereby interfering with cellular signaling pathways. The therapeutic...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sun Yat-sen University Cancer Center
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3777484/ https://ncbi.nlm.nih.gov/pubmed/22237041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.011.10315 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|